Last reviewed · How we verify

NCT04749992: BFD

Biological Function of Dreaming in Dreaming and Non-Dreaming Patients With PCA Infarction

Terminated Last updated 12 March 2024
What this trial tests

trial testing Polysomnographic examination in sleep laboratory (PSG measurement) in Dream Disorder in 142 participants. Terminated before completion.

Timeline
1 August 2018
Primary endpoint
8 March 2024
8 March 2024

Quick facts

Lead sponsorInternational Psychoanalytic University Berlin
StatusTerminated
Study typeOBSERVATIONAL
Enrollment142
Start date1 August 2018
Primary completion8 March 2024
Estimated completion8 March 2024
Sites2 locations across Germany

Drugs / interventions tested

Conditions studied

Sponsor

International Psychoanalytic University Berlin

Who can join

Adults 18 to 90, any sex, with Dream Disorder or Thrombotic Infarction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a quasi-experimental between-group design. Using a prospective two-arm controlled exploratory study, data will be collected on an initial assessment of the effects of a specific neurological sample after thrombotic infarction (PCA infarction) who lost the ability to dream due to the infarction (experimental group) compared to a specific neurological sample after thrombotic infarction (PCA infarction) without loss of the ability to dream (comparison group) in terms of subjective and objective sleep quality and memory consolidation. Besides the importance to further elucidate the role of dreaming for sleep architecture and memory consolidation, the results of the evaluation are of great clinical relevance in a further scientific investigation regarding the treatment of a specifically neurological sample with acute thrombotic infarction.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Converging theories on dreaming: Between Freud, predictive processing, and psychedelic research.
    Koslowski M, de Haas MP, Fischmann T. · · 2023 · cited 8× · PMID 36875230 · DOI 10.3389/fnhum.2023.1080177
  2. Exploring the biological function of dreaming: lessons learned from recruitment challenges in a pilot study with PCA stroke patients.
    Fischmann T, Peters L, Rieker V, Koslowski M. · · 2025 · PMID 41425211 · DOI 10.3389/frsle.2025.1585263

Verify or expand the search:

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04749992.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing